chr11-17572162-T-C
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001292063.2(OTOG):āc.2038T>Cā(p.Ser680Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.436 in 1,549,820 control chromosomes in the GnomAD database, including 150,699 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Consequence
NM_001292063.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OTOG | NM_001292063.2 | c.2038T>C | p.Ser680Pro | missense_variant | 18/56 | ENST00000399397.6 | NP_001278992.1 | |
OTOG | NM_001277269.2 | c.2074T>C | p.Ser692Pro | missense_variant | 17/55 | NP_001264198.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OTOG | ENST00000399397.6 | c.2038T>C | p.Ser680Pro | missense_variant | 18/56 | 5 | NM_001292063.2 | ENSP00000382329 | P2 | |
OTOG | ENST00000399391.7 | c.2074T>C | p.Ser692Pro | missense_variant | 17/55 | 5 | ENSP00000382323 | A2 |
Frequencies
GnomAD3 genomes AF: 0.470 AC: 71314AN: 151694Hom.: 17741 Cov.: 31
GnomAD3 exomes AF: 0.390 AC: 57374AN: 146938Hom.: 11892 AF XY: 0.394 AC XY: 31206AN XY: 79252
GnomAD4 exome AF: 0.432 AC: 604619AN: 1398008Hom.: 132933 Cov.: 49 AF XY: 0.431 AC XY: 297309AN XY: 689536
GnomAD4 genome AF: 0.470 AC: 71385AN: 151812Hom.: 17766 Cov.: 31 AF XY: 0.465 AC XY: 34477AN XY: 74190
ClinVar
Submissions by phenotype
not specified Benign:4
Benign, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 09, 2017 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Nov 24, 2014 | Ser692Pro in exon 17 of OTOG: This variant is not expected to have clinical sign ificance because it has been identified in 72.2% (140/194) of Luhya (Kenyan) chr omosomes from a broad population by the 1000 Genomes Project (http://www.ncbi.nl m.nih.gov/projects/SNP; dbSNP rs7106548). - |
Benign, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Autosomal recessive nonsyndromic hearing loss 18B Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Sep 05, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at